Alkem Laboratories Limited
Morgan Stanley bought 48,090 shares of Alkem Laboratories for ₹25.01 Cr at ₹5200.00 apiece in a block deal on June 2, 2026. This was part of a larger transaction where promoter family entities sold 17.88 lakh shares worth ₹930 crore.
A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.
US-based global investment bank. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.